Description
Tirzepatide Research Peptide
Tirzepatide is a synthetic dual GIP/GLP-1 receptor agonist supplied for controlled laboratory investigation. Researchers study its mechanism of action, which involves the activation of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its defined 39-amino acid sequence, incorporating a C-20 fatty diacid moiety, allows for consistent and repeatable studies under standardized experimental conditions examining incretin pathway dynamics.
Because of its specific dual receptor agonism, researchers value Tirzepatide for investigating the synergistic effects of incretin pathway activation in metabolic research models. Studies utilizing this compound aim to elucidate signaling patterns, receptor interaction behavior, and downstream cellular responses in controlled environments. The consistent composition of Tirzepatide facilitates data consistency and the precise examination of compound-specific mechanisms relevant to glucose homeostasis and metabolic regulation.
In laboratory settings, Tirzepatide is handled and prepared following standard peptide preparation and safety procedures. It is supplied as a lyophilized powder. Store in cool, dry conditions. Reconstitute with bacteriostatic water for solution. Refrigerate at 2-8°C after reconstitution, or freeze at -20°C for extended storage to maintain compound integrity and stability for research applications.
The consistent composition and defined structure of Tirzepatide provide high consistency, making it compatible with structured research workflows. Its reliable behavior reduces experimental variation, supporting long-term laboratory projects focused on metabolic pathways and receptor pharmacology, ensuring data reproducibility across experiments.
Ongoing research continues to include Tirzepatide as a key compound for investigating complex metabolic signaling. Its defined sequence and stable behavior make it suitable for controlled research models examining glucose homeostasis and incretin system dynamics with precision and accuracy.
Important Notice: Tirzepatide 20mg is provided strictly for research use only. This product is not intended for human or animal use, clinical applications, diagnostic procedures, or consumption of any kind. All research must be conducted by qualified professionals in appropriate laboratory environments and in compliance with applicable regulations and guidelines.
Frequently Asked Questions
What is Tirzepatide?
Tirzepatide is a synthetic peptide, consisting of 39 amino acids, classified as a dual GIP/GLP-1 receptor agonist. It is supplied for research purposes to investigate its specific role in activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, thereby influencing glucose-dependent insulinotropic signaling pathways in controlled laboratory settings.
What is the structural significance of Tirzepatide’s C-20 fatty diacid moiety?
The C-20 fatty diacid moiety incorporated into Tirzepatide’s structure is a key modification that influences its pharmacokinetic profile in research models. This structural feature is studied for its role in extending the compound’s half-life, which can lead to sustained receptor interaction and prolonged effects, allowing for more comprehensive studies on its metabolic impact over time.
What biological systems are studied using Tirzepatide?
Tirzepatide is primarily used in research to study biological systems involved in glucose homeostasis and metabolic regulation. This includes investigations into pancreatic islet function, insulin secretion mechanisms, and the broader incretin pathway signaling. Researchers often focus on its effects on glucose metabolism and its unique dual receptor activation in controlled experimental settings.
How does Tirzepatide activate dual incretin pathways in research models?
Tirzepatide functions as an agonist for both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual agonism is hypothesized to induce synergistic effects on glucose-dependent insulin secretion and other metabolic parameters, allowing researchers to explore the combined impact of activating these two key incretin pathways in laboratory studies.
Why is Tirzepatide of interest in metabolic research?
Tirzepatide is of interest in metabolic research due to its novel dual GIP/GLP-1 receptor agonism, offering a unique mechanism for investigating complex metabolic interactions beyond single incretin activation. Researchers are particularly interested in its potential to modulate multiple aspects of glucose homeostasis, energy metabolism, and receptor pharmacology within controlled laboratory environments, providing insights into integrated metabolic responses.
What are the recommended storage conditions for Tirzepatide in a laboratory setting?
As a lyophilized powder, Tirzepatide should be stored in a cool, dry place, protected from light. After reconstitution with bacteriostatic water, the solution should be refrigerated at 2-8°C. For extended storage and to maintain its stability and integrity for future research applications, freezing at -20°C is recommended. Proper storage ensures the compound’s reliability for consistent experimental outcomes.
Reviews
There are no reviews yet.